Author
1. Moreno Jose M Ruiz
2. Montero Javier A
ISBN
9789350903209
DOI
10.5005/jp/books/11828_37
Edition
3/e
Publishing Year
2013
Pages
11
Author Affiliations
1.
Albacete Medical School, Castilla La Macha University, Avendia de Almansa, 14, Albacete, Spain,
Miguel Hernandez University School of Medicine, 03550, Alicante, Spain,
Albacete Medical School, University of Castilla La Mancha, Avenida Almansa, Albacete, Spain
2.
Alicante Institute of Ophthalmology, Alicante, Spain,
Instituto Oftalmologico de Alicante, Alicante, Spain,
University Hospital Valladolid, VISSUM, Alicante, Spain,
Pio del Rio Hortega University, Hospital, Ophthalmology Unit, C/Rondilla de Sta Teresa 9, Valladolid, 47010, Spain,
Pio del Rio Hortega University, Hospital, Valladolid, VISSUM, Alicante, Spain,
Pío del Río Hortega University Hospital, Valladolid, Spain, Alicante Institute of Ophthalmology, VISSUM, Alicante, Spain,
Pio del Rio Hortega University Hospital, Valladolid, VISSUM, Alicante, Spain,
Pío del Río Hortega University Hospital, Valladolid, Spain; Alicante Institute of Ophthalmology, Alicante, Spain,
Pio del Rio Hortega, University Hospital, Valladolid, Spain,
Pio del Rio Hortega University, Valladolid, Spain
Chapter keywords
Photodynamic therapy,
myopic subfoveal choroidal neovascularization,
visual acuity,
intravitreal injection,
antiangiogenic drugs,
intravitreal bevacizumab,
ranibizumab,
glaucomatous damage
